You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -633.3% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -27.5 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 220.5 | 0.0 |
Price / Book value | 22.3 |
Latest | Forecast | |
---|---|---|
Revenue | 936.4% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2017-01-31 | n/a | -16.20 | -4.91p | -1.8 | 0.0 | n/a | n/a | 0.0% |
2018-01-31 | n/a | -6.72 | -2.00p | -4.8 | 0.0 | n/a | n/a | 0.0% |
2019-01-31 | 0.04 | -5.09 | -1.49p | -3.5 | 0.0 | n/a | n/a | 0.0% |
2020-01-31 | 0.46 | -2.87 | -0.87p | -4.3 | 0.0 | n/a | n/a | 0.0% |
e-Therapeutics 're-energised' by Mortazavi appointment Sharecast News | 12 Oct |
---|---|
E-therapeutics enters collaboration deal with Galapagos Sharecast News | 10 Jun |
Holding(s) in Company | 25-Feb-21 15:30 |
---|---|
e-therapeutics to present at Shares Evening | 16-Feb-21 07:00 |
Holding(s) in Company | 10-Feb-21 16:37 |
RNA Therapeutics Platform | 01-Feb-21 07:00 |
Second Price Monitoring Extn | 28-Jan-21 16:44 |